executive

Visioneering Technologies Appoints Benoit as Executive Director of Professional Affairs

ATLANTA—Visioneering Technologies Inc. (VTI), a global company dedicated to improving vision care, has named Douglas P. Benoit, OD, FAAO, executive director, professional affairs, a new position at the company. Dr. Benoit will be responsible for working with eyecare professionals to increase awareness and use of the NaturalVue 1 Day Contact Lenses product line and its advanced-technology designs. He also will work with professional organizations and educational institutions to raise awareness of VTI and its NaturalVue products. “The appointment of Dr. Benoit comes at an important time for VTI, as we expand our sales force nationwide to better meet the needs…


Novartis Chief Executive Jimenez to Retire in 2018, Narasimhan Named Successor

Joseph Jimenez (l) will retire next year and be succeeded by Vasant (Vas) Narasimhan, MD.​ BASEL, Switzerland—Novartis AG (NYSE: NVS) chief executive officer Joseph Jimenez, who has led the company since 2010, announced Monday that he plans to step down as CEO in January and retire from the company on Aug. 31, 2018. The pharma company, which also owns Alcon, said its board of directors has appointed Vasant (Vas) Narasimhan, MD, the company’s global head of drug development and chief medical officer, to succeed Jimenez, effective Feb. 1, 2018. Dr. Narasimhan, a member of the company’s executive committee, joined Novartis…


Visioneering Technologies, Inc. Names Rosa Lee Executive Director of Manufacturing and Engineering

Rosa Lee.​ ALPHARETTA, Ga.—Visioneering Technologies, Inc. (VTI), has named Rosa Lee to the position of executive director of Manufacturing and Engineering. Lee will direct the manufacturing and product optimization efforts for the company. “Rosa is a seasoned, passionate, and detail oriented professional with extensive experience in optical design, manufacturing, research and development,” said Dr. Sally M. Dillehay, chief medical officer, vice president, Clinical Regulatory Affairs, CEO of Visioneering Technologies. “Her expertise in contact lens design optimization will be a significant addition to the VTI Team, and help us to accelerate our new product development efforts.” Lee received her B.S. and…


Allergan Streamlines Executive Team in Business Realignment

DUBLIN—During Allergan’s (NYSE: AGN) conference call with investors earlier this week, Brent Saunders, the company’s president and CEO, announced “a streamlined executive team to lead Allergan going forward.” Saunders said, “I have been carefully considering how to streamline our management structure to better align our resources as a focused branded Growth Pharma business with many leading global brands. In this new leadership structure, all of our commercial businesses will be combined under Bill Meury, who has been appointed our chief commercial officer.” Previously, Meury had served as Allergan’s executive vice president and president, Branded Pharma. Saunders also announced the appointment…


Pfizer Names Executive Team for Combined Organization Upon Completion of Allergan Transaction

NEW YORK—Pfizer Inc. (NYSE: PFE) has announced the executive leadership team for the combined Pfizer and Allergan plc (NYSE: AGN) business following the close of the proposed transaction, which is expected to be completed in the second half of this year. As previously announced, following the closing, Brent Saunders will become president and chief operating officer of the combined company with responsibility for the oversight of Pfizer and Allergan’s combined commercial businesses, manufacturing and strategy functions. Effective immediately and through the closing of the transaction, Pfizer’s Global Innovative Pharma (GIP) business and its Vaccines, Oncology and Consumer (VOC) business will…